Accunia Competitors

Stocks . Denmark . 
Stock . Accunia Invest EUR
ACACIGDKK  DKK 983.50  7.90  0.80%   
  
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Accunia Invest's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
983.02983.50983.98
Details
Intrinsic
Valuation
LowRealHigh
880.76881.241,082
Details
Naive
Forecast
LowNextHigh
983.17983.65984.14
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
975.92983.98992.04
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Accunia Invest. Your research has to be compared to or analyzed against Accunia Invest's peers to derive any actionable benefits. When done correctly, Accunia Invest's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Accunia Invest EUR.

Accunia Invest Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Accunia Invest and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Accunia and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Accunia Invest EUR does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
MAERSK-A
+ 0.98
MAERSK-B
MAERSK-A
+ 0.89
DSV
MAERSK-B
+ 0.88
DSV
GMAB
+ 0.72
NOVO-B
COLO-B
+ 0.64
GMAB
COLO-B
+ 0.59
NOVO-B
  
High negative correlations   
MAERSK-B
- 0.92
NOVO-B
MAERSK-A
- 0.89
NOVO-B
DSV
- 0.85
NOVO-B
GMAB
- 0.73
MAERSK-B
COLO-B
- 0.69
MAERSK-A
COLO-B
- 0.69
MAERSK-B

Risk-Adjusted Indicators

There is a big difference between Accunia Stock performing well and Accunia Invest Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Accunia Invest's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
NOVO-B  1.31  0.27  0.17  1.07  1.06 
(1.52)
 3.56 
(1.86)
 10.55 
NDA-DK  1.06  0.02 (0.04)(0.02) 1.91 
(0.91)
 1.70 
(2.38)
 7.45 
DSV  0.97 (0.28) 0.00  4.43  0.00 
 0.00 
 1.69 
(2.28)
 5.34 
MAERSK-B  1.80 (0.35) 0.00  1.09  0.00 
 0.00 
 2.83 
(3.36)
 17.69 
MAERSK-A  1.61 (0.27) 0.00  0.87  0.00 
 0.00 
 2.74 
(2.81)
 17.58 
ORSTED  1.80 (0.01)(0.04) 0.20  2.21 
(1.70)
 3.76 
(3.28)
 9.31 
VWS  1.36 (0.16) 0.00 (0.61) 0.00 
 0.00 
 2.91 
(2.97)
 9.89 
GMAB  1.38  0.04 (0.05) 0.00  1.68 
(1.53)
 2.95 
(2.80)
 9.79 
COLO-B  1.07  0.27  0.16  0.65  0.98 
(1.15)
 1.88 
(2.05)
 12.51 
CARL-B  0.81  0.09  0.02  0.65  0.89 
(0.94)
 2.20 
(1.59)
 7.20 

Accunia Invest Competitive Analysis

The better you understand Accunia Invest competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Accunia Invest's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Accunia Invest's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
ACACIGDKK NOVO-B NDA-DK DSV MAERSK-B MAERSK-A ORSTED VWS GMAB COLO-B
 0.80 
 983.50 
Accunia
 1.41 
 878.70 
Novo
 2.38 
 81.90 
Nordea
 5.29 
 1,020 
DSV
 0.59 
 9,856 
MAERSK-B
 0.52 
 9,660 
MAERSK-A
 1.82 
 382.20 
Orsted
 2.42 
 181.10 
Vestas
 1.79 
 1,972 
Genmab
 0.59 
 922.00 
Coloplast
Market Volatility
(90 Days Market Risk)
Very steady
Very steady
Very steady
Very steady
Very steady
Very steady
Very steady
Very steady
Very steady
Very steady
Market Performance
(90 Days Performance)
Modest
Good
Very Weak
Very Weak
Very Weak
Very Weak
Very Weak
Very Weak
Weak
Good
Odds of Financial Distress
(Probability Of Bankruptcy)
About Average
Low
Low
Low
Low
Low
Low
Low
Low
Low
Current Valuation
(Equity Enterprise Value)
Over Valued
Under Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Under Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Cautious Hold
Strong Buy
Strong Sell
Sell
Strong Sell
Strong Sell
Strong Sell
Cautious Hold
Strong Sell
Strong Buy
Current Ratio
N/A
1.06
N/A
1.01
1.37
1.13
1.95
1.02
15.42
1.12
Net Asset
N/A
241.26 B
594.84 B
159.04 B
93.68 B
93.68 B
314.14 B
20.09 B
24.63 B
34.96 B
Profit Margin
N/A
0.31
0.37
0.0746
0.36
0.36
0.11
-0.11
0.47
0.2
EBITDA
N/A
76.8 B
N/A
24.6 B
37.18 B
37.18 B
32.72 B
(545 M)
4.24 B
7.23 B
Operating Margin
N/A
0.43
0.5
0.11
0.38
0.38
0.0855
-0.0721
0.38
0.3
Current Valuation
N/A
2.1 T
464.06 B
269.42 B
207.26 B
207.26 B
323.55 B
217.13 B
186.33 B
203.46 B
Price To Book
N/A
27.51
1.18
3.03
0.63
0.62
5.54
7.51
7.86
22.36
Retained Earnings
N/A
36.07 B
N/A
7.4 B
31.8 B
31.08 B
N/A
2.57 B
N/A
4.7 B
Current Asset
N/A
46.38 B
N/A
17 B
11.27 B
10.73 B
N/A
6.33 B
N/A
6.01 B
Five Year Return
N/A
2.45
N/A
0.37
2.16
2.24
N/A
1.29
N/A
2.29
Beta
N/A
0.33
0.9
1.08
1.37
1.37
0.56
1.16
0.67
0.21
Number Of Employees
N/A
54.39 K
28.27 K
76.28 K
110 K
110 K
8.03 K
28.44 K
1.56 K
14.5 K
Shares Outstanding
N/A
1.72 B
3.62 B
216.26 M
7.38 M
10.11 M
420.23 M
1.01 B
65.96 M
194.31 M
Cash Flow From Operations
N/A
78.89 B
21.98 B
26.85 B
34.48 B
34.48 B
11.92 B
(195 M)
2.23 B
5.1 B
Annual Yield
N/A
0.0115
0.0727
0.0051
0.28
0.17
0.0212
0.0017
N/A
0.0252
Total Debt
N/A
20.77 B
N/A
21.4 B
3.77 B
3.77 B
60.45 B
1.96 B
378 M
16.36 B
Return On Equity
N/A
0.72
0.11
0.24
0.53
0.53
0.17
-0.41
0.24
0.75
Z Score
N/A
64.2
N/A
8.8
43.2
42.6
2.4
64.8
N/A
6.0
Return On Asset
N/A
0.22
0.0062
0.0982
0.23
0.23
0.0242
-0.0328
0.1
0.17
Book Value Per Share
N/A
37.1
8.63
329.73
3632.12
3632.12
217.83
3.03
408.67
27.81
Current Liabilities
N/A
41.07 B
N/A
15.02 B
9.61 B
9.29 B
N/A
5.26 B
N/A
4.78 B
Total Asset
N/A
241.26 B
594.84 B
159.04 B
93.68 B
93.68 B
314.14 B
20.09 B
24.63 B
34.96 B
Debt To Equity
N/A
0.21
N/A
0.56
54.2
62.8
43.1
0.5
0.018
43.4
Target Price
N/A
975.48
93.87
1387.35
20832.7
12250.0
745.0
497.32
3239.73
954.18
Last Dividend Paid
N/A
12.4
0.8
6.5
623.0
623.0
13.5
N/A
N/A
20.0
Shares Owned By Institutions
N/A
38.87
60.54
49.3
53.82
58.88
24.45
46.64
49.9
25.53
Market Capitalization
N/A
2.24 T
302.44 B
281.93 B
274.76 B
270.01 B
269.87 B
212.24 B
185.21 B
175.43 B
Price To Earning
N/A
37.49
N/A
56.94
58.43
53.81
13.2
27.15
34.78
42.1
Price To Earnings To Growth
N/A
2.0
9.0
3.73
0.35
0.34
6.36
2.36
1.19
3.38
Price To Sales
N/A
12.16
28.93
0.95
3.13
3.04
2.15
14.28
17.0
7.79
Net Income
N/A
55.52 B
3.6 B
17.57 B
29.2 B
29.2 B
15.13 B
(1.57 B)
3.01 B
4.71 B
Earnings Per Share
N/A
24.44
6.96
76.2
11054.63
11054.63
34.6
-3.89
83.21
21.76
Shares Owned By Insiders
N/A
N/A
0.72
17.0
5.3
19.93
55.0
0.06
N/A
35.0
Revenue
N/A
176.95 B
9.79 B
235.66 B
81.53 B
81.53 B
126.09 B
14.49 B
8.48 B
22.58 B
Working Capital
N/A
5.31 B
N/A
1.98 B
1.66 B
1.44 B
N/A
1.07 B
N/A
1.23 B
Cash And Equivalents
N/A
27.22 B
N/A
2.03 B
5 B
4.96 B
25.31 B
1.92 B
18.08 B
620 M
Cash Per Share
N/A
11.83
N/A
9.22
242.74
246.39
60.26
1.9
276.57
2.92
Gross Profit
N/A
148.51 B
9.72 B
52.15 B
36.73 B
36.73 B
35.11 B
118 M
8.48 B
15.53 B
Day Typical Price
984.07
883.43
82.6
1026.5
9885.67
9690.0
384.43
182.77
1985.33
922.47
Accumulation Distribution
0.0897
0.0186
0.025
0.0278
0.0229
0.0224
0.0259
0.0269
0.0199
0.0093
Market Facilitation Index
0.0327
16.6
2.1
29.0
229.0
220.0
10.1
5.0
40.0
8.6
Daily Balance Of Power
(4.65)
(0.76)
(0.95)
(1.97)
0.2533
0.2273
(0.70)
(0.90)
(0.90)
0.6279
Period Momentum Indicator
(7.90)
(12.60)
(2.00)
(57.00)
58.0
50.0
(7.10)
(4.50)
(36.00)
5.4
Rate Of Daily Change
0.99
0.99
0.98
0.95
1.01
1.01
0.98
0.98
0.98
1.01
Day Median Price
984.35
885.8
82.95
1030.0
9900.5
9705.0
385.55
183.6
1992.0
922.7
Price Action Indicator
(4.80)
(13.40)
(2.05)
(39.00)
(15.50)
(20.00)
(6.90)
(4.75)
(38.00)
2.0
Coefficient Of Variation
1163.41
591.86
10540.84
(499.79)
(708.83)
(901.57)
177105.93
(1,409)
25625.87
547.08
Mean Deviation
0.3686
1.31
1.06
0.9686
1.8
1.61
1.8
1.36
1.38
1.07
Jensen Alpha
0.0271
0.2714
0.0234
(0.28)
(0.35)
(0.27)
(0.01)
(0.16)
0.042
0.2656
Total Risk Alpha
(0.03)
0.0692
(0.18)
(0.46)
(0.71)
(0.61)
(0.28)
(0.37)
(0.23)
0.089
Sortino Ratio
(0.06)
0.1654
(0.04)
N/A
N/A
N/A
(0.04)
N/A
(0.05)
0.1635
Downside Variance
0.4408
1.69
3.83
N/A
N/A
N/A
5.07
N/A
3.0
1.88
Standard Deviation
0.5441
1.79
1.47
1.37
2.63
2.56
2.18
1.82
1.85
1.71
Kurtosis
0.8457
5.0
3.61
2.56
12.57
16.69
(0.58)
1.6
0.8763
14.64
Potential Upside
1.03
3.56
1.7
1.69
2.83
2.74
3.76
2.91
2.95
1.88
Treynor Ratio
0.2955
1.07
(0.02)
4.43
1.09
0.865
0.2035
(0.61)
0.0048
0.6498
Maximum Drawdown
2.75
10.55
7.45
5.34
17.69
17.58
9.31
9.89
9.79
12.51
Variance
0.296
3.21
2.16
1.88
6.9
6.55
4.73
3.32
3.43
2.91
Market Risk Adjusted Performance
0.3055
1.08
(0.01)
4.44
1.1
0.875
0.2135
(0.60)
0.0148
0.6598
Risk Adjusted Performance
0.0522
0.112
0.0117
(0.12)
(0.08)
(0.06)
0.0075
(0.04)
0.0091
0.1204
Skewness
(0.33)
1.56
(1.59)
(0.45)
(2.47)
(2.99)
0.1338
0.6631
0.3871
2.61
Semi Deviation
0.4822
1.06
1.91
N/A
N/A
N/A
2.21
N/A
1.68
0.9783
Information Ratio
(0.08)
0.1199
(0.05)
(0.26)
(0.17)
(0.15)
(0.04)
(0.12)
(0.04)
0.1313
Value At Risk
(0.94)
(1.86)
(2.38)
(2.28)
(3.36)
(2.81)
(3.28)
(2.97)
(2.80)
(2.05)
Expected Short fall
(0.34)
(1.52)
(0.91)
N/A
N/A
N/A
(1.70)
N/A
(1.53)
(1.15)
Downside Deviation
0.664
1.3
1.96
N/A
N/A
N/A
2.25
N/A
1.73
1.37
Semi Variance
0.2325
1.13
3.67
N/A
N/A
N/A
4.9
N/A
2.82
0.957

Accunia Invest Competition Performance Charts

Five steps to successful analysis of Accunia Invest Competition

Accunia Invest's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Accunia Invest EUR in relation to its competition. Accunia Invest's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Accunia Invest in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Accunia Invest's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Accunia Invest EUR, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Accunia Invest position

In addition to having Accunia Invest in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Entertainment Thematic Idea Now

Entertainment
Entertainment Theme
Companies from entertainment industry including show business, news and media. The Entertainment theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Entertainment Theme or any other thematic opportunities.
View All  Next Launch
Check out Accunia Invest Correlation with its peers.
You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Complementary Tools for Accunia Stock analysis

When running Accunia Invest's price analysis, check to measure Accunia Invest's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Accunia Invest is operating at the current time. Most of Accunia Invest's value examination focuses on studying past and present price action to predict the probability of Accunia Invest's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Accunia Invest's price. Additionally, you may evaluate how the addition of Accunia Invest to your portfolios can decrease your overall portfolio volatility.
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Please note, there is a significant difference between Accunia Invest's value and its price as these two are different measures arrived at by different means. Investors typically determine if Accunia Invest is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Accunia Invest's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY